INTC
33
-2
BBY
46
10
PAYX
53
2
SE
61
-4
HAS
33
3
CAH
48
-5
HP
48
3
HOG
35
2
DOW
44
10
JWN
48
6
CMG
72
5
AON
54
2
TGT
22
2
WU
32
2
BMY
60
2
MCD
52
2
KEY
46
3
URI
65
5
HD
57
2
CL
58
2
INTC
33
-2
BBY
46
10
PAYX
53
2
SE
61
-4
HAS
33
3
CAH
48
-5
HP
48
3
HOG
35
2
DOW
44
10
JWN
48
6
CMG
72
5
AON
54
2
TGT
22
2
WU
32
2
BMY
60
2
MCD
52
2
KEY
46
3
URI
65
5
HD
57
2
CL
58
2
Financhill
Back

Cognition Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

CGTX
Cognition Therapeutics

Last Price:
0.43
Seasonality Move:
14.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Cognition Therapeutics Price Quote

$0.43
+0.00 (+-2.23%)
(Updated: November 23, 2024 at 5:29 AM ET)

Cognition Therapeutics Key Stats

Sell
33
Cognition Therapeutics (CGTX) is a Sell
Day range:
$0.41 - $0.45
52-week range:
$0.34 - $2.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.23%
Volume:
261.9K
Avg. volume:
552K
1-year change:
-55.45%
Market cap:
$17.8M
Revenue:
$0
EPS:
$-0.97

How Much Does Cognition Therapeutics Make?

Data Unavailable

Is Cognition Therapeutics Growing As A Company?

Data Unavailable

Cognition Therapeutics Stock Price Performance

What Is Cognition Therapeutics 52-Week High & Low?

Cognition Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cognition Therapeutics?

Is Cognition Therapeutics Cash Flow Positive?

  • What Is CGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$25.5M
  • What Is Cognition Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.6M
  • What Is Cognition Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$33K

Cognition Therapeutics Return On Invested Capital

Data Unavailable

Cognition Therapeutics Earnings Date & Stock Price

Cognition Therapeutics Competitors

Cognition Therapeutics Dividend Yield

Cognition Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.19%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 6.20
Upside from Last Price: 1349.61%

Major Shareholders

  • How many CGTX shares are owned by institutional investors?
    13.9M CGTX shares are owned by institutional investors
  • How many CGTX shares are owned by insiders?
    672.7K CGTX shares are owned by insiders